This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Covidien Announces Investor Meeting Agenda

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 12, 2013. The event will be held at Cipriani, 55 Wall Street, New York, NY. A webcast of the presentations will begin at approximately 2:20 pm ET and will conclude by 5:00 pm ET.

The program will begin with rotational sessions where attendees will visit Covidien's product displays, hear from industry experts discussing how Covidien technology is being used and learn about the Company’s early stage growth opportunities. Following these sessions will be formal presentations by Covidien's Chairman, President and Chief Executive Officer José (Joe) E. Almeida and other Covidien leaders, as well as Q&A with members of the senior management team.

For those investors who are unable to attend the meeting in person, but would like to ask a question of the management team during the meeting, questions can be emailed to 2013cov@gmail.com.

Agenda

9:30 a.m. Registration Opens10:00 a.m. – 2:15 p.m. Rotational Sessions

  • Product Displays; Senior Management interaction
  • Clinical Perspectives on Covidien Technology
  • Covidien’s Early Stage Growth Opportunities

2:20 p.m. Senior Management Presentations

  • José (Joe) E. Almeida, Chairman, President and CEO
  • Brian D. King, President, Emerging Markets
  • Q&A with Senior Management Team

4:05 p.m. Charles J. Dockendorff, Chief Financial Officer4:30 p.m. Financial Q&A5:00 p.m. Presentations and webcast end

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: http://survey.covidien.com/f/537189/1e8a/.

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien’s website: http://investor.covidien.com. A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading products in medical devices and supplies. With 2012 revenue of $9.9 billion, Covidien has 38,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs